View More Recent Stories

Aug 5, 2020 04:01PM PTC Therapeutics Reports Second Quarter 2020 Financial Results and Provides a Corporate Update
Jul 21, 2020 09:00AM PTC Therapeutics to Host Deep Dive Webinar on Splicing Platform
Jul 20, 2020 07:31AM PTC Therapeutics (PTCT) to Monetize Portion of Risdiplam Royalty Stream for $650 Million
Jul 20, 2020 07:30AM PTC Therapeutics Announces Agreement to Monetize a Portion of the Risdiplam Royalty Stream for $650 Million
Jul 8, 2020 08:01AM PTC Therapeutics (PTCT) Reports First Patient Dosed in Phase 1 Trial for PTC857
Jul 8, 2020 08:00AM PTC Therapeutics Announces First Patient Dosed in Phase 1 Trial for PTC857
Jun 29, 2020 08:01AM PTC Therapeutics (PTCT) Announces CHMP Recommendation of Translarna Label Update for Non-Ambulatory Patients with DMD
Jun 29, 2020 08:00AM PTC Therapeutics Announces CHMP Recommendation of Translarna™ (ataluren) Label Update for Non-Ambulatory Patients with Duchenne Muscular Dystrophy
Jun 17, 2020 06:32AM PTC Therapeutics (PTCT) Commences Phase 2/3 Clinical Trial to Evaluate PTC299 for Treatment of COVID-19
Jun 17, 2020 06:30AM PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19
Jun 12, 2020 04:18PM PTC Therapeutics (PTCT) Announces 2-year Data from Part 1 of SUNFISH and New Data from JEWELFISH Trials for Risdiplam in Patients with SMA
Jun 12, 2020 04:15PM PTC Therapeutics Announces 2-year Data from Part 1 of SUNFISH and New Data from JEWELFISH Trials for Risdiplam in Patients with Spinal Muscular Atrophy
Jun 10, 2020 08:00AM PTC Therapeutics Launches New "Talent Pipeline Program" to Help Students who Graduated During the 2020 COVID-19 Pandemic
Jun 1, 2020 08:00AM PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals
May 28, 2020 09:00AM PTC Therapeutics to Host First Deep Dive Webinar on Bio-e Platform
May 6, 2020 05:33PM PTC Therapeutics (PTCT) to Acquire Censa Pharmaceuticals
May 6, 2020 04:30PM PTC Therapeutics to Acquire Censa Pharmaceuticals
Apr 28, 2020 01:00AM Confirmatory Part 2 of FIREFISH Demonstrates Survival and Motor Milestones Not Seen in Natural History in Infants with Type 1 Spinal Muscular Atrophy
Apr 17, 2020 08:00AM PTC Therapeutics Announces New Leadership Appointments
Apr 7, 2020 04:08PM PTC Therapeutics (PTCT) Announces FDA Has Extended PDUFA Date for Risdiplam NDA to August 24
Apr 7, 2020 04:05PM PTC Announces Regulatory Update on Risdiplam for Spinal Muscular Atrophy (SMA)
Feb 18, 2020 08:00AM PTC Therapeutics Launches Sixth Annual STRIVE Awards Program for Advocacy Organizations in Duchenne Muscular Dystrophy
Feb 3, 2020 08:06AM PTC Therapeutics (PTCT) Announces First Publication of Real-World Data Showing Translarna Significantly Preserves Ability to Walk for Longer in Children with DMD
Feb 3, 2020 08:00AM PTC Therapeutics Announces First Publication of Real-World Data Showing Translarnaä (ataluren) Significantly Preserves Ability to Walk for Longer in Children with Duchenne Muscular Dystrophy
Nov 18, 2019 08:00AM PTC Therapeutics Launches A No-Cost Testing Program to Drive AADC Deficiency Patient Identification
Nov 12, 2019 07:30AM Intrexon Reports Third Quarter 2019 Financial Results
Nov 11, 2019 01:00AM Risdiplam (RG7916) Pivotal SUNFISH Study Demonstrates Statistically Significant Improvement for Patients with Type 2/3 Spinal Muscular Atrophy
Oct 29, 2019 04:01PM PTC Therapeutics Reports Third Quarter 2019 Financial Results and Provides a Corporate Update
Oct 24, 2019 08:09AM PTC Therapeutics (PTCT) Announces Results from Long-Term AADC Deficiency Gene Therapy Treatment Demonstrating Sustained Improvements
Oct 24, 2019 08:00AM PTC Therapeutics Announces Results from Long-Term AADC Deficiency Gene Therapy Treatment Demonstrating Sustained Improvements
Oct 7, 2019 08:00AM PTC Therapeutics Establishes Strategic Collaboration with Aldevron to Support GMP Plasmid Manufacturing
Oct 4, 2019 08:02AM PTC Therapeutics (PTCT) Reports Data from STRIDE Registry Demonstrating Translarna (ataluren) Slows Disease Progression in Patients with Duchenne Muscular Dystrophy
Oct 4, 2019 08:00AM PTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna™ (ataluren) Slows Disease Progression in Patients with Duchenne Muscular Dystrophy
Oct 2, 2019 08:06AM PTC Therapeutics (PTCT) Announces Risdiplam SMA Data Demonstrating Continued Benefit Presented at World Muscle Society Congress
Oct 2, 2019 08:00AM Risdiplam Spinal Muscular Atrophy Data Demonstrating Continued Benefit Presented at World Muscle Society Congress
Sep 6, 2019 08:00AM PTC Therapeutics Celebrates the Fifth Anniversary of STRIVE Grant Awards by Announcing 2019 Award Winners
Aug 6, 2019 04:01PM PTC Therapeutics Reports Second Quarter 2019 Financial Results and Provides a Corporate Update
Aug 5, 2019 08:00AM PTC Therapeutics Expands Presence in New Jersey by Securing State-of-the-Art Biologics Facility
Jul 1, 2019 08:07AM PTC Therapeutics (PTCT) Announces Strategic Gene Therapy Licensing Agreement with Odylia Therapeutics
Jul 1, 2019 08:00AM PTC Therapeutics Announces Strategic Gene Therapy Licensing Agreement with Odylia Therapeutics
Jun 28, 2019 08:16AM PTC Therapeutics (PTCT) Announces CHMP Adopts Negative Opinion of Translarna Application for Label Expansion
Jun 28, 2019 06:40AM PTC Provides Update on Translarna™ (ataluren) Application for Label Expansion
Nov 14, 2016 09:24AM Pre-Open Stock Movers 11/14: (CRBP) (HAR) (DGII) (MENT) Higher; (DVAX) (HEAR) (ACM) Lower (more...)
Feb 23, 2016 05:27PM INVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims Against PTC Therapeutics, Inc. and Strongly Encourages Investors to Contact the Firm
Feb 23, 2016 09:30AM Pre-Open Stock Movers 02/23: (NEWP) (MMSI) (TXRH) Higher; (PTCT) (FIT) (WDC) Lower (more...)
Oct 16, 2015 12:09PM Streetinsider.com's Hot Lunchtime Reads 10/16: (AAPL) (TWTR) (PTCT) (ZFGN)
Feb 23, 2015 12:28PM PTC Therapeutics (PTCT) Pares Move Higher Following M&A Speculation (BMRN)
View More Recent Stories